Divi's Laboratories Limited (BOM:532488)
India · Delayed Price · Currency is INR 6,072.60
+69.75 (1.16%)
At close: Jan 22, 2026
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 1.61 trillion as of January 23, 2026. Its market cap has increased by 3.04% in one year.
Market Cap
1.61T
Enterprise Value
1.58T
Revenue
100.29B
Ranking
n/a
PE Ratio
64.86
Stock Price
6,072.60
Market Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 1.61T, an increase of 79,076.96%. That is a compound annual growth rate of 33.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 1.60T | -5.96% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 174.23B |
| Sudeep Pharma | 60.82B |
| Shilpa Medicare | 54.48B |
| Gujarat Themis Biosyn | 36.48B |
| Suven Life Sciences | 30.77B |
| IOL Chemicals and Pharmaceuticals | 21.01B |
| Bajaj HealthCare | 11.56B |
| NGL Fine-Chem | 9.43B |